April L Kennedy

USPTO Granted Patents = 10 (Patent Applications = 1)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 7.5

ph-index = 4

Forward Citations = 183(Granted Patents)

Location History:

Boulder, CO (US) (2005 - 2015)
Denver, CO (US) (2009 - 2020)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2005-2020

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10669269 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors (2020-06-02),

2. 9809590 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors (2017-11-07),

3. 9174981 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors (2015-11-03),

4. 8841455 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors (2014-09-23),

5. 8299021 - Macrocyclic inhibitors of hepatitis C virus replication (2012-10-30),

6. 7932277 - Peptide inhibitors of hepatitis C virus replication (2011-04-26),

7. 7829665 - Macrocyclic inhibitors of hepatitis C virus replication (2010-11-09),

8. 7781474 - Inhibitors of hepatitis C virus replication (2010-08-24),

9. 7491794 - Macrocyclic compounds as inhibitors of viral replication (2009-02-17),

10. 6911554 - Isocyano substituted polystyrene carbonate resin for use in 3 and 4 component condensation reactions (2005-06-28),

Title: Spotlight on Inventor April L Kennedy from Denver, CO (US)

Introduction:

April L Kennedy, a talented inventor hailing from Denver, CO, has made significant contributions in the field of pharmaceuticals with an impressive portfolio of 10 patents.

Latest Patents:

One of her latest patents includes the development of Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors. These compounds have shown promise in treating a variety of conditions such as fibrosis, bone-related diseases, cancer, autoimmune disorders, and cardiovascular diseases among others.

Career Highlights:

April L Kennedy has showcased her expertise while working at esteemed companies such as Array Biopharma Inc. and Intermune, Inc. Her innovative approach and dedication to advancing pharmaceutical research have led to groundbreaking discoveries in the medical field.

Collaborations:

Throughout her career, April has collaborated with exceptional individuals like Lawrence M Blatt and Steven Wade Andrews. Together, they have worked on cutting-edge projects that have the potential to revolutionize the way certain diseases are treated.

Conclusion:

Inventor April L Kennedy's remarkable journey and groundbreaking inventions have solidified her position as a trailblazer in the pharmaceutical industry. Her relentless pursuit of excellence and commitment to improving healthcare have left a lasting impact on the field of medicine.

This text is generated by artificial intelligence and may not be accurate.